Study of Ibrutinib in Subjects With Acute Myeloid Leukemia
Clinical trial NCT02351037 · TERMINATED
Trial details
- NCT number
- NCT02351037
- Sponsor
- Pharmacyclics LLC.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2017-04-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.